Molekule Group (Molekule Group) Accounts Receivable : $2.21 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Molekule Group's accounts receivables for the quarter that ended in Jun. 2023 was $2.21 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Molekule Group's Days Sales Outstanding for the quarter that ended in Jun. 2023 was 15.23.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Molekule Group's Net-Net Working Capital per share for the quarter that ended in Jun. 2023 was $-1.85.

Molekule Group Accounts Receivable Historical Data

The historical data trend for Molekule Group's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group Accounts Receivable Chart

Molekule Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Accounts Receivable

0.18

0.04

Molekule Group Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Accounts Receivable	Get a 7-Day Free Trial									0.03	0.01	0.04	1.01	2.21

Molekule Group Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Molekule Group Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Molekule Group's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	2.211	/	13.243	*	91
=	15.23

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Molekule Group's accounts receivable are only considered to be worth 75% of book value:

Molekule Group's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(5.269	+	0.75 * 2.211	+	0.5 * 29.433	-	84.735
-	0	-	0)	/	34.0465
=	-1.85

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Molekule Group Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Molekule Group's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Molekule Group (Molekule Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (OTCPK:MKULQ) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410

Website

https://www.molekule.com

Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.

Executives

Ritankar Pal	officer: Chief Operating Officer	10455 RIVERSIDE DR., PALM BEACH GARDENS FL 33410
Jonathan Harris	officer: Chief Commercial Officer	3000 CLEARVIEW WAY, SAN MATEO CA 94402
Bradley A Feld	director	C/O FOUNDRY GROUP, 645 WALNUT ST., BOULDER CO 80302
Ryan A Mcintyre	10 percent owner
Seth Levine	10 percent owner	1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Fg Next Gp, Llc	10 percent owner	1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Foundry Group Next, L.p.	10 percent owner	C/O FOUNDRY GROUP, 1050 WALNUT STREET, SUITE 219, BOULDER CO 80302
Ward Jr Stephen M	director	C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612
Timothy J Scannell	director	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Heather Floyd	director	1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Thomas P Mccaffrey	director	1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Lewis C Pell	10 percent owner	C/O VISION SCIENCES INC, 6 STRATHMORE RD, NATICK MA 01760
Michael F Senft	director	1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Jason Dibona	officer: Chief Executive Officer	10455 RIVERSIDE DRIVE, PALM BEACH GARDEN FL 33410
David Helfet	director	10455 RIVERSIDE DRIVE, PALM BEACH GARDENS FL 33410